Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03161431 |
| Title | SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Syntrix Biosystems, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Miami | RECRUITING | Miami | Florida | 33136 | United States | Details |
| Massachusetts General Hospital Cancer Center | ACTIVE_NOT_RECRUITING | Boston | Massachusetts | 02114 | United States | Details |
| Dana-Farber Cancer Institute | ACTIVE_NOT_RECRUITING | Boston | Massachusetts | 02215 | United States | Details |
| Mayo Clinic | RECRUITING | Rochester | Minnesota | 55905 | United States | Details |
| Wilmot Cancer Institute - University of Rochester | RECRUITING | Rochester | New York | 14642 | United States | Details |
| MD Anderson | RECRUITING | Houston | Texas | 77030 | United States | Details |